Article thumbnail

The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1β and IL-18 Production

By Deepti Verma, Eva Särndahl, Henrik Andersson, Per Eriksson, Mats Fredrikson, Jan-Ingvar Jönsson, Maria Lerm and Peter Söderkvist
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2009). A
  2. (2004). Aluminium compounds for use in vaccines.
  3. (2007). Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release.
  4. (2000). Arguments for interleukin 1 as a target in chronic arthritis.
  5. (2003). ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis.
  6. (2005). ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP.
  7. (1996). Biologic basis for interleukin-1 in disease.
  8. (1998). Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling.
  9. (2007). Coexistent MEFV and CIAS1 mutations manifesting as familial Mediterranean fever plus deafness.
  10. (2009). Combined polymorphisms in genes encoding the inflammasome components Activating Polymorphism
  11. (2007). Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.
  12. (2011). Cross-regulation between the IL-1beta/ IL-18 processing inflammasome and other inflammatory cytokines.
  13. (2008). Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
  14. (2007). Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling.
  15. (2004). Cryopyrininduced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC.
  16. (2006). Cutting edge: ASC mediates the induction of multiple cytokines by Porphyromonas gingivalis via caspase-1-dependent and -independent pathways.
  17. (2008). Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3.
  18. (2009). Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression.
  19. (2009). Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation.
  20. (2002). De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
  21. (2007). Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity.
  22. (2009). Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease.
  23. (2008). Gene polymorphisms in the NALP3 inflammasome are associated with interleukin-1 production and severe inflammation: relation to common inflammatory diseases?
  24. (2008). Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology (Oxford)
  25. (2005). Hereditary periodic Fever syndromes. Hematology Am Soc Hematol Educ Program.
  26. (2010). Hypoxia mediates low cell-cycle activity and increases the proportion of long-termreconstituting hematopoietic stem cells during in vitro culture.
  27. (2004). Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.
  28. (2003). Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4.
  29. (1987). Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.
  30. (2002). Livneh A
  31. (2007). Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.
  32. (2005). Modulation of Toll-interleukin 1 receptor mediated signaling.
  33. (2007). Monocytes from familial cold autoinflammatory syndrome patients are activated by mild hypothermia.
  34. (2004). NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.
  35. (2007). NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta.
  36. (2007). Nonclassic neurologic features in cryopyrin-associated periodic syndromes.
  37. (2007). Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
  38. (2012). PLoS ONE
  39. (2006). Refractory autoinflammatory syndrome associated with digenic transmission of low-penetrance tumour necrosis factor receptor-associated periodic syndrome and cryopyrinassociated periodic syndrome mutations.
  40. (1992). Serum levels of interleukin-1b, tumour necrosis factor-a and interleukin-2 in rheumatoid arthritis. Correlation with disease activity.
  41. (2007). The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.
  42. (2010). The inflammasomes.
  43. (2008). The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity.
  44. (2009). The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.
  45. (2000). The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1.
  46. (2005). The tumour necrosis factor receptorassociated periodic syndrome: current concepts.
  47. (2010). Two adult siblings with atypical cryopyrin-associated periodic syndrome due to a novel M299V mutation in NLRP3.
  48. (2010). Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.